We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$602M
AUM Growth
+$46.8M
Cap. Flow
+$8.45M
Cap. Flow %
1.4%
Top 10 Hldgs %
66.65%
Holding
35
New
5
Increased
14
Reduced
12
Closed
3

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$29.2M
2
GILD icon
Gilead Sciences
GILD
+$13.3M
3
MRK icon
Merck
MRK
+$11.2M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.91M
5
PRGO icon
Perrigo
PRGO
+$4.75M

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$13.8M
2
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$12.3M
3
AGN
Allergan plc
AGN
+$10.8M
4
BSX icon
Boston Scientific
BSX
+$8.45M
5
LLY icon
Eli Lilly
LLY
+$5.82M

Sector Composition

Rank Sector Weight
1 Healthcare 98.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
26
Ultragenyx Pharmaceutical
RARE
$2.65B
$5.23M 0.87%
+68,015
New +$4.39M
ALNY icon
27
Alnylam Pharmaceuticals
ALNY
$36.3B
$3.2M 0.53%
+32,500
New +$3.22M
THC icon
28
Tenet Healthcare
THC
$20.1B
$3.04M 0.5%
90,503
-443,518
-83% -$13.8M
BLUE
29
DELISTED
bluebird bio
BLUE
$2.67M 0.44%
+1,312
New +$2.99M
ONCE
30
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.62M 0.43%
31,600
-15,000
-32% -$1.16M
SGMO
31
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.07M 0.34%
146,000
+50,000
+52% +$831K
RGNX icon
32
Regenxbio
RGNX
$623M
$718K 0.12%
+10,000
New +$478K
AGIO icon
33
Agios Pharmaceuticals
AGIO
$2.16B
– –
-41,000
Closed -$3.35M
SRPT icon
34
Sarepta Therapeutics
SRPT
$1.66B
– –
-51,006
Closed -$3.78M
AGN
35
DELISTED
Allergan plc
AGN
– –
-64,300
Closed -$10.8M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2018 Portfolio in Review

As of Q2 2018, Sector Gamma AS held 35 positions worth $602M, up 8.4% from $555M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Sector Gamma AS's Q2 2018 filing shows 5 new, 14 increased, 12 reduced and 3 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 28,500 shares worth $9.83M. The largest sale was Tenet Healthcare, an estimated $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier.

  • Sector Gamma AS's largest Q2 2018 buy was Regeneron Pharmaceuticals: 28,500 shares worth $9.83M.
  • Sector Gamma AS added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.2M increase.
  • Sector Gamma AS's biggest Q2 2018 reduction was Tenet Healthcare, cutting an estimated $13.8M.
  • Sector Gamma AS fully exited Allergan plc in Q2 2018, selling an estimated $10.8M.
  • Sector Gamma AS's ten largest holdings make up 67% of its $602M portfolio in Q2 2018.
  • Sector Gamma AS opened 5 new positions and closed 3 in Q2 2018.
  • Sector Gamma AS's portfolio value rose 8.4% quarter-over-quarter to $602M.

Based on Sector Gamma AS's 13F filing for Q2 2018, filed 2 Aug 2018.